herenciageneticayenfermedad: Parkinson's Disease - Nov 6, 2018 Edition :: Medical News

martes, 6 de noviembre de 2018

Parkinson's Disease - Nov 6, 2018 Edition :: Medical News | Medical Articles

	November 6, 2018
	Parkinson's Disease
	The latest Parkinson's disease news from News Medical

Occupational Therapy for Parkinson’s Disease

Parkinson’s disease is a neurodegenerative disorder which affects the motor and non-motor systems within the human brain. As a result of this, those with the disorder develop deficits in mobility, dexterity and executive functioning.

			Physiotherapy for Parkinson's Disease Parkinson’s disease is one of the most prevalent neurodegenerative disorders affecting the motor and non-motor systems within the human brain.

			Progressive Supranuclear Palsy (PSP) Versus Parkinson's Disease Progressive Supranuclear Palsy (PSP) is a neurodegenerative disease, caused by the accumulation of tau proteins in the brain. The formation of clumps of tau proteins is thought to result in damage to the nerve cells and thus causes defects in cognition, eye movements, and posture.

	Parkinson’s diagnoses expected to increase by 20% A surge in Parkinson’s diagnoses is expected for people over the age of 60. Parkinson’s UK’s latest figures show that there are currently more than 77,000 people in the UK with Parkinson’s between the ages of 60 and 79. This is projected to increase by 20 percent by the year 2025 to more than 92,000. Currently, there is no cure and treatments are limited.

	New transgenic mouse model sheds light on biological causes of Parkinson's disease Parkinson's disease is a neurodegenerative disorder that presents clinically with abnormal movement and tremors at rest.

	Newly discovered compound shows potential for treating Parkinson's disease A joint research group centered around Professor Hideyuki Okano and Associate Professor Jun Kohyama, Department of Physiology of the Keio University School of Medicine, together with a research group of Eisai Co., Ltd. has identified a compound that has the potential to be a treatment for Parkinson's disease by using dopaminergic neurons differentiated from induced pluripotent stem (iPS) cells from patients with familial Parkinson's disease.

	Targeting immune checkpoints in microglia could reduce out-of-control neuroinflammation A group of Massachusetts General Hospital investigators is proposing that targeting immune checkpoints - molecules that regulate the activity of the immune system - in immune cells called microglia could reduce the inflammatory aspects of important neurodegenerative diseases like Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

	The appendix may be associated with Parkinson’s disease The vermiform appendix or appendix as we commonly know it, is a vestigial organ of the body which does not come into notice unless it is inflamed (such as in appendicitis). In cases of appendicitis, the finger like part of the gut at the base of the caecum is surgically removed.

	Developing Better Treatment With Small Molecules Potential treatments for neurological disorders, such as Alzheimer's and Parkinson's, are being studied by looking at small molecules which target the brain.